Disentangling reproductive history and parenthood in late-life cognitive and vascular brain health.
文献摘要
Women bear a greater burden of Alzheimer's disease (AD), prompting interest in whether reproductive history contributes to late-life brain health. Yet parity, a count of live births, compresses biologically and socially distinct reproductive trajectories into a single measure. Current human biomarker studies provide little evidence that parity tracks amyloid-β or tau pathology. The clearest human evidence links adverse pregnancy outcomes (APOs), particularly hypertensive disorders of pregnancy (HDP), to later vascular brain injury and vascular dementia, supporting a life-course vascular framework that separates preconception susceptibility, pregnancy complications, and postpartum recovery. Mother-father comparisons further indicate that parenthood-related social exposures contribute to the observed associations. Obstetric history therefore has direct relevance to vascular risk assessment, whereas AD biomarker testing should follow established clinical and biomarker indications rather than parity. Future studies should pair exposure-resolved reproductive histories with serial postpartum phenotyping, vascular neuroimaging, and longitudinal AD biomarkers.